200 related articles for article (PubMed ID: 37323177)
1. Targeting complement C5a to improve radiotherapy sensitivity in non-small cell lung cancer.
Yuan M; Wang C; Wu Y; Qiao L; Deng G; Liang N; Chen F; Liu L; Chen Y; Yang Y; Wang H; Liu T; Yang X; Zhang Y; Lv Y; Suwinski R; Hu P; Zhang Y; Zhang J
Transl Lung Cancer Res; 2023 May; 12(5):1093-1107. PubMed ID: 37323177
[TBL] [Abstract][Full Text] [Related]
2. Blockade of C5a receptor unleashes tumor-associated macrophage antitumor response and enhances CXCL9-dependent CD8
Luan X; Lei T; Fang J; Liu X; Fu H; Li Y; Chu W; Jiang P; Tong C; Qi H; Fu Y
Mol Ther; 2024 Feb; 32(2):469-489. PubMed ID: 38098230
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of C5aR1 and C5aR2 in innate and adaptive immune cells located in early skin lesions of bullous pemphigoid patients.
Emtenani S; Holtsche MM; Stahlkopf R; Seiler DL; Burn T; Liu H; Parker M; Yilmaz K; Dikmen HO; Lang MH; Sadik CD; Karsten CM; van Beek N; Ludwig RJ; Köhl J; Schmidt E
Front Immunol; 2022; 13():942493. PubMed ID: 36466856
[TBL] [Abstract][Full Text] [Related]
4. Complement C5a/C5aR pathway potentiates the pathogenesis of gastric cancer by down-regulating p21 expression.
Chen J; Li GQ; Zhang L; Tang M; Cao X; Xu GL; Wu YZ
Cancer Lett; 2018 Jan; 412():30-36. PubMed ID: 29031586
[TBL] [Abstract][Full Text] [Related]
5. Mesenchymal stem cells alleviate acute kidney injury by down-regulating C5a/C5aR pathway activation.
Tang M; Zhang K; Li Y; He QH; Li GQ; Zheng QY; Zhang KQ
Int Urol Nephrol; 2018 Aug; 50(8):1545-1553. PubMed ID: 29594894
[TBL] [Abstract][Full Text] [Related]
6. C5a/C5aR1 mediates IMQ-induced psoriasiform skin inflammation by promoting IL-17A production from γδ-T cells.
Zheng QY; Xu F; Yang Y; Sun DD; Zhong Y; Wu S; Li GQ; Gao WW; Wang T; Xu GL; Liang SJ
FASEB J; 2020 Aug; 34(8):10590-10604. PubMed ID: 32557852
[TBL] [Abstract][Full Text] [Related]
7. Complement C5aR1 Signaling Promotes Polarization and Proliferation of Embryonic Neural Progenitor Cells through PKCζ.
Coulthard LG; Hawksworth OA; Li R; Balachandran A; Lee JD; Sepehrband F; Kurniawan N; Jeanes A; Simmons DG; Wolvetang E; Woodruff TM
J Neurosci; 2017 May; 37(22):5395-5407. PubMed ID: 28455369
[TBL] [Abstract][Full Text] [Related]
8. Blockade of the Complement C5a/C5aR1 Axis Impairs Lung Cancer Bone Metastasis by CXCL16-mediated Effects.
Ajona D; Zandueta C; Corrales L; Moreno H; Pajares MJ; Ortiz-Espinosa S; Martínez-Terroba E; Perurena N; de Miguel FJ; Jantus-Lewintre E; Camps C; Vicent S; Agorreta J; Montuenga LM; Pio R; Lecanda F
Am J Respir Crit Care Med; 2018 May; 197(9):1164-1176. PubMed ID: 29327939
[TBL] [Abstract][Full Text] [Related]
9. C5a receptors C5aR1 and C5aR2 mediate opposing pathologies in a mouse model of melanoma.
Nabizadeh JA; Manthey HD; Panagides N; Steyn FJ; Lee JD; Li XX; Akhir FNM; Chen W; Boyle GM; Taylor SM; Woodruff TM; Rolfe BE
FASEB J; 2019 Oct; 33(10):11060-11071. PubMed ID: 31298935
[TBL] [Abstract][Full Text] [Related]
10. Improving radiotherapy in immunosuppressive microenvironments by targeting complement receptor C5aR1.
Beach C; MacLean D; Majorova D; Melemenidis S; Nambiar DK; Kim RK; Valbuena GN; Guglietta S; Krieg C; Darvish-Damavandi M; Suwa T; Easton A; Hillson LV; McCulloch AK; McMahon RK; Pennel K; Edwards J; O'Cathail SM; Roxburgh CS; Domingo E; Moon EJ; Jiang D; Jiang Y; Zhang Q; Koong AC; Woodruff TM; Graves EE; Maughan T; Buczacki SJ; Stucki M; Le QT; Leedham SJ; Giaccia AJ; Olcina MM
J Clin Invest; 2023 Dec; 133(23):. PubMed ID: 37824211
[TBL] [Abstract][Full Text] [Related]
11. C5aR deficiency attenuates the breast cancer development via the p38/p21 axis.
Chen J; Sun ZH; Chen LY; Xu F; Zhao YP; Li GQ; Tang M; Li Y; Zheng QY; Wang SF; Yang XH; Wu YZ; Xu GL
Aging (Albany NY); 2020 Jul; 12(14):14285-14299. PubMed ID: 32669478
[TBL] [Abstract][Full Text] [Related]
12. C5a receptor1 inhibition alleviates influenza virus-induced acute lung injury.
Song N; Li P; Jiang Y; Sun H; Cui J; Zhao G; Li D; Guo Y; Chen Y; Gao J; Sun S; Zhou Y
Int Immunopharmacol; 2018 Jun; 59():12-20. PubMed ID: 29621732
[TBL] [Abstract][Full Text] [Related]
13. C5a/C5aR pathway accelerates renal ischemia-reperfusion injury by downregulating PGRN expression.
Zhang K; Li GQ; He QH; Li Y; Tang M; Zheng QY; Xu GL; Zhang KQ
Int Immunopharmacol; 2017 Dec; 53():17-23. PubMed ID: 29031143
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of human cancer cell motility and invasiveness by anaphylatoxin C5a via aberrantly expressed C5a receptor (CD88).
Nitta H; Wada Y; Kawano Y; Murakami Y; Irie A; Taniguchi K; Kikuchi K; Yamada G; Suzuki K; Honda J; Wilson-Morifuji M; Araki N; Eto M; Baba H; Imamura T
Clin Cancer Res; 2013 Apr; 19(8):2004-13. PubMed ID: 23287562
[TBL] [Abstract][Full Text] [Related]
15. The C5aR1 complement receptor: A novel immunomodulator of insulin action in skeletal muscle.
Shah DS; McNeilly AD; McCrimmon RJ; Hundal HS
Cell Signal; 2024 Jan; 113():110944. PubMed ID: 37890688
[TBL] [Abstract][Full Text] [Related]
16. Prostate cancer C5a receptor expression and augmentation of cancer cell proliferation, invasion, and PD-L1 expression by C5a.
Imamura R; Kitagawa S; Kubo T; Irie A; Kariu T; Yoneda M; Kamba T; Imamura T
Prostate; 2021 Feb; 81(3):147-156. PubMed ID: 33368414
[TBL] [Abstract][Full Text] [Related]
17. Platelets promote CRC by activating the C5a/C5aR1 axis via PSGL-1/JNK/STAT1 signaling in tumor-associated macrophages.
Li X; Chen X; Gong S; Zhao J; Yao C; Zhu H; Xiao R; Qin Y; Li R; Sun N; Li X; Dong F; Zhao T; Pan Y; Yang J
Theranostics; 2023; 13(6):2040-2056. PubMed ID: 37064877
[No Abstract] [Full Text] [Related]
18. Complement 5a stimulates macrophage polarization and contributes to tumor metastases of colon cancer.
Piao C; Zhang WM; Li TT; Zhang CC; Qiu S; Liu Y; Liu S; Jin M; Jia LX; Song WC; Du J
Exp Cell Res; 2018 May; 366(2):127-138. PubMed ID: 29551360
[TBL] [Abstract][Full Text] [Related]
19. Complement drives glucosylceramide accumulation and tissue inflammation in Gaucher disease.
Pandey MK; Burrow TA; Rani R; Martin LJ; Witte D; Setchell KD; Mckay MA; Magnusen AF; Zhang W; Liou B; Köhl J; Grabowski GA
Nature; 2017 Mar; 543(7643):108-112. PubMed ID: 28225753
[TBL] [Abstract][Full Text] [Related]
20. Complement activation product C5a is a selective suppressor of TLR4-induced, but not TLR3-induced, production of IL-27(p28) from macrophages.
Bosmann M; Haggadone MD; Hemmila MR; Zetoune FS; Sarma JV; Ward PA
J Immunol; 2012 May; 188(10):5086-93. PubMed ID: 22491257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
